Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Blood-brain barrier opening with focused ultrasound in Parkinson’s disease dementia
Carmen Gasca‐Salas, Beatriz Fernández‐Rodríguez, José A. Pineda‐Pardo, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 208

Showing 1-25 of 208 citing articles:

Bacteria loaded with glucose polymer and photosensitive ICG silicon-nanoparticles for glioblastoma photothermal immunotherapy
Rong Sun, Mingzhu Liu, Jianping Lu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 124
Repeated blood–brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial
Adam M. Sonabend, Andrew Gould, Christina Amidei, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 5, pp. 509-522
Open Access | Times Cited: 119
Magnetic iron oxide nanoparticles for brain imaging and drug delivery
Ruirui Qiao, Changkui Fu, Helen Forgham, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114822-114822
Open Access | Times Cited: 108
Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors
Li Zhang, Yue Liu, Haiyan Huang, et al.
Advanced Drug Delivery Reviews (2022) Vol. 190, pp. 114536-114536
Closed Access | Times Cited: 103
Ultrasound Blood–Brain Barrier Opening and Aducanumab in Alzheimer’s Disease
Ali R. Rezai, Pierre-François D’Haese, Victor Finomore, et al.
New England Journal of Medicine (2024) Vol. 390, Iss. 1, pp. 55-62
Closed Access | Times Cited: 101
Ultrasound-mediated blood–brain barrier opening: An effective drug delivery system for theranostics of brain diseases
Jieqiong Wang, Zhenzhou Li, Min Pan, et al.
Advanced Drug Delivery Reviews (2022) Vol. 190, pp. 114539-114539
Closed Access | Times Cited: 75
Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier
Shuai Zha, Haitao Liu, Hengde Li, et al.
ACS Nano (2024) Vol. 18, Iss. 3, pp. 1820-1845
Open Access | Times Cited: 73
Applications of focused ultrasound-mediated blood-brain barrier opening
Catherine M. Gorick, Victoria R. Breza, Katherine M. Nowak, et al.
Advanced Drug Delivery Reviews (2022) Vol. 191, pp. 114583-114583
Open Access | Times Cited: 72
Chiral metal-organic frameworks incorporating nanozymes as neuroinflammation inhibitors for managing Parkinson’s disease
Wei Jiang, Qing Li, Ruofei Zhang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 61
Highly piezoelectric, biodegradable, and flexible amino acid nanofibers for medical applications
Meysam T. Chorsi, Thinh T. Le, Feng Lin, et al.
Science Advances (2023) Vol. 9, Iss. 24
Open Access | Times Cited: 57
BBB opening with focused ultrasound in nonhuman primates and Parkinson’s disease patients: Targeted AAV vector delivery and PET imaging
Javier Blesa, José A. Pineda‐Pardo, Ken‐ichi Inoue, et al.
Science Advances (2023) Vol. 9, Iss. 16
Open Access | Times Cited: 40
Ultrasound-responsive microbubbles and nanodroplets: A pathway to targeted drug delivery
Gazendra Shakya, Marco Cattaneo, Giulia Guerriero, et al.
Advanced Drug Delivery Reviews (2024) Vol. 206, pp. 115178-115178
Open Access | Times Cited: 27
Focused ultrasound gene delivery for the treatment of neurological disorders
Rikke Hahn Kofoed, Isabelle Aubert
Trends in Molecular Medicine (2024) Vol. 30, Iss. 3, pp. 263-277
Open Access | Times Cited: 15
Therapeutics in the Pipeline Targetingα-Synuclein for Parkinson's Disease
Hilary Grosso Jasutkar, Stephanie Oh, M. Maral Mouradian
Pharmacological Reviews (2022) Vol. 74, Iss. 1, pp. 207-237
Open Access | Times Cited: 66
Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
Jiayi Zeng, Xiangxue Li, Max Sander, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 62
Anti-Parkinsonian Therapy: Strategies for Crossing the Blood–Brain Barrier and Nano-Biological Effects of Nanomaterials
Guowang Cheng, Yujing Liu, Rui Ma, et al.
Nano-Micro Letters (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 62
Making waves: how ultrasound-targeted drug delivery is changing pharmaceutical approaches
Lauren J. Delaney, Selin Isguven, John R. Eisenbrey, et al.
Materials Advances (2022) Vol. 3, Iss. 7, pp. 3023-3040
Open Access | Times Cited: 54
Ultrasound-Mediated Blood–Brain Barrier Disruption for Drug Delivery: A Systematic Review of Protocols, Efficacy, and Safety Outcomes from Preclinical and Clinical Studies
Kushan Gandhi, Anita Barzegar‐Fallah, Ashik Banstola, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 833-833
Open Access | Times Cited: 48
Striatal Blood–Brain Barrier Opening in Parkinson's Disease Dementia: A Pilot Exploratory Study
José A. Pineda‐Pardo, Carmen Gasca‐Salas, Beatriz Fernández‐Rodríguez, et al.
Movement Disorders (2022) Vol. 37, Iss. 10, pp. 2057-2065
Closed Access | Times Cited: 44
Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
Sindhu Menon, Sabrina E.M. Armstrong, Amir Mohammad Hamzeh, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 43
Putaminal Recombinant Glucocerebrosidase Delivery with Magnetic Resonance–Guided Focused Ultrasound in Parkinson's Disease: A Phase I Study
Ying Meng, Christopher B. Pople, Yuexi Huang, et al.
Movement Disorders (2022) Vol. 37, Iss. 10, pp. 2134-2139
Open Access | Times Cited: 40
Current Treatments and New, Tentative Therapies for Parkinson’s Disease
Teresa Pardo-Moreno, Victoria García‐Morales, Nora Suleiman‐Martos, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 770-770
Open Access | Times Cited: 37
Non-Invasive Drug Delivery across the Blood–Brain Barrier: A Prospective Analysis
Sarfaraz K. Niazi
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2599-2599
Open Access | Times Cited: 37
Fluorescence, ultrasonic and photoacoustic imaging for analysis and diagnosis of diseases
Binbin Chu, Zhiming Chen, Haoliang Shi, et al.
Chemical Communications (2023) Vol. 59, Iss. 17, pp. 2399-2412
Closed Access | Times Cited: 33
Micro/nanosystems for controllable drug delivery to the brain
Mingzhen Tian, Zhichao Ma, Guang‐Zhong Yang
The Innovation (2023) Vol. 5, Iss. 1, pp. 100548-100548
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top